Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011;74(22-24):1460-8.
doi: 10.1080/15287394.2011.618973.

Upregulation of micro RNA-146a (miRNA-146a), a marker for inflammatory neurodegeneration, in sporadic Creutzfeldt-Jakob disease (sCJD) and Gerstmann-Straussler-Scheinker (GSS) syndrome

Affiliations

Upregulation of micro RNA-146a (miRNA-146a), a marker for inflammatory neurodegeneration, in sporadic Creutzfeldt-Jakob disease (sCJD) and Gerstmann-Straussler-Scheinker (GSS) syndrome

W J Lukiw et al. J Toxicol Environ Health A. 2011.

Abstract

A mouse- and human-brain-abundant, nuclear factor (NF)-кB-regulated, micro RNA-146a (miRNA-146a) is an important modulator of the innate immune response and inflammatory signaling in specific immunological and brain cell types. Levels of miRNA-146a are induced in human brain cells challenged with at least five different species of single- or double-stranded DNA or RNA neurotrophic viruses, suggesting a broad role for miRNA-146a in the brain's innate immune response and antiviral immunity. Upregulated miRNA-146a is also observed in pro-inflammatory cytokine-, Aβ42 peptide- and neurotoxic metal-induced, oxidatively stressed human neuronal-glial primary cell cocultures, in murine scrapie and in Alzheimer's disease (AD) brain. In AD, miRNA-146a levels are found to progressively increase with disease severity and co-localize to brain regions enriched in inflammatory neuropathology. This study provides evidence of upregulation of miRNA-146a in extremely rare (incidence 1-10 per 100 million) human prion-based neurodegenerative disorders, including sporadic Creutzfeldt-Jakob disease (sCJD) and Gerstmann-Straussler-Scheinker syndrome (GSS). The findings suggest that an upregulated miRNA-146a may be integral to innate immune or inflammatory brain cell responses in prion-mediated infections and to progressive and irreversible neurodegeneration of both the murine and human brain.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
(A) Homo sapiens micro RNA-146a (hsa-miRNA-146a) is a 22-nucleotide small RNA (highlighted in yellow) abundant in mouse and human immune cells and the limbic system, with known mRNA 3′ UTR targets that include the interleukin-1 receptor associated kinase 1 (IRAK-1; highlighted in red); uppercase ribonucleotides involved in fully (|) or partially (:) complementary hydrogen bonding (Cui et al. 2010; Taganov et al. 2006); chromosome location of the human IRAK-1 gene (chrXq28) and Genbank accession (NM_01569.3) indicated; EA = predicted energy of association for miRNA-mRNA interaction (Sethi and Lukiw 2009; miRBASE, Cambridge, UK); the mouse and human miRNA-146a are identical in sequence (Li et al. 2010a; 2010b; Sethi and Lukiw 2009). (B) Structural features of the miRNA-146a encoding DNA locus at chromosome 5q33.3 and details of the NF-κB-sensitive miRNA146a gene showing three upstream (5′) regulatory NF-КB binding sites; miRNA-146a transcription is highly NF-КB sensitive (Cui et al. 2010; Lukiw et al. 2008; Taganov et al. 2006). (C) The pre-miRNA-146a transcribed from the miRNA146a locus (chr 5q33.3) has strong potential to form a highly stable 35-base-pair stem, 60-nucleotide loop RNA structure (stem-loop EA= −49.5 kcal/mol); other predicted secondary structures of alternate stem-loop configurations are possible and the 5′ and 3′ ends of pre-miRNA-146a may be significantly extended. In several preferential EA models, such as the one depicted in (C), the stem-loop structure containing the miRNA-146a sequence is consistently located in the very distal end of the predicted loop (highlighted in yellow; delineated by arrows), after which Dicer (RNase III) processing of this pre-miRNA-146a (Yokota 2009) yields the mature miRNA-146a highlighted in yellow in (A) (color figure available online).
FIGURE 2
FIGURE 2
Abundance of hsa-miRNA-125b and/or hsa-miRNA-146a in comparison to an internal control hsa-5S RNA marker in murine scrapie 139a, sporadic Creutzfeldt-Jakob disease (sCJD), and Gerstmann-Straussler-Scheinker syndrome (GSS) compared to age-matched controls (control) in the same brain region as analyzed by (A) fluorescent miRNA array cluster analysis (LC Sciences, Houston TX) and (B) concentrated Northern dot-blot analysis of 5S RNA and miRNA-146a using high-specific-activity radiolabeled probes (Cui et al. 2005; Sethi and Lukiw 2009); (C) quantified results from Northern dot-blot analysis; dashed horizontal line indicates control 139A levels relative to 5S RNA for ease of comparison. In (A) panel 1 is the age-matched control for murine 139a (n= 2; lanes 4 and 5); lanes 2 and 3 are the mean age-matched control for the individual cases for sCJD (n = 3; lanes 6–8) and GSS (n= 2, lanes 9 and 10), respectively; by convention, green colors indicate no change and red colors indicate upregulation (LC Sciences; Lukiw et al. 2008). Squared black lines to the left of panel (A) indicate that a mean signal intensity comparison between hsa-5S–RNAand hsa-miRNA-125b yielded a significance of p > .07 (ANOVA), and between 5S–RNA and hsa-miRNA-146a yielded a p< .01 (ANOVA). miRNA-125b was found to be significantly upregulated in one of two GSS cases and two of three CJD cases; miRNA-146a was found to be consistently elevated in all sCJD or GSS cases using miRNA array analysis; and this was further confirmed using quantitative Northern dot blot analysis (B and C). The 22 nucleotide hsa-5S–RNA probe was derived from the 5′ end of the 107 nucleotide human 5S ribosomal RNA (5S RNA) and in panel (B) was loaded at 1/10 the concentration of miRNA-146a (Sethi and Lukiw 2009) (color figure available online).

Similar articles

Cited by

References

    1. Alexandrov PN, Zhao Y, Pogue AI, Tarr MA, Kruck TP, Percy ME, Cui JG, Lukiw WJ. Synergistic effects of iron and aluminum on stress-related gene expression in primary human neural cells. J. Alzheimers Dis. 2005;8:117–127. - PubMed
    1. Aronica E, Fluiter K, Iyer A, Zurolo E, Vreijling J, van Vliet EA, Baayen JC, Gorter JA. Expression pattern of miR-146a, an inflammation-associated microRNA, in experimental and human temporal lobe epilepsy. Eur. J. Neurosci. 2010;31:1100–1107. - PubMed
    1. Barbato C, Ruberti F, Cogoni C. Searching for MIND: microRNAs in neurodegenerative diseases. J. Biomed Biotechnol. 2009;2009:871313. - PMC - PubMed
    1. Burmistrova OA, Goltsov AY, Abramova LI, Kaleda VG, Orlova VA, Rogaev EI. MicroRNA in schizophrenia: Genetic and expression analysis of miR-130b (22q11) Biochemistry (Moscow) 2007;72:578–582. - PubMed
    1. Collins S, McLean CA, Masters CL. Gerstmann–Sträussler–Scheinker syndrome, fatal familial insomnia, and kuru: A review of these less common human transmissible spongiform encephalopathies. J. Clin. Neurosci. 2001;8:387–397. - PubMed

Publication types

MeSH terms